Standard Bots CEO Evan Beard wants to build the world's largest robot maker in the US — and persuade Washington to help his industry take on China. https://t.co/gFgx2zgtDP
What % of adults are more excited than concerned about AI? I opened a talk last weekend with that question, to a room full of brilliant frontier AI researchers. Hands went up. 70%! 50%! 60%! 80%!
I then shared the data. The answer is 9%, and it's trending down. It caused quite a stir. So, how does public trust come back? When people rank dozens of possible AI futures, the one they see as most beneficial and least risky is AI that improves our health. I went on to explain why current approaches in AI understanding biology are both critical and insufficient. And why AI companies need to integrate their algorithms directly into the cell, using light as a digital actuator. I provided a roadmap for how to use that to make all biological products, and how it could completely transform human and planetary health.
Parts of the deck I presented is attached, and the essay that inspired it is in the comments. Feel free to share with anyone who you think might be interested!
Stellios Founder and CEO Richard Starson told us that fusion-powered space travel is closer than people think, and that trips to Mars could end up taking weeks not months:
"I think that today fusion is in a similar time as AI was in 2017–2018, when transformers were invented but ChatGPT did not appear yet. The building blocks of compact fusion are already there."
"There are multiple companies that will get to fusion. Most of them are focused on electricity generation. We believe we have a design that can make fusion energy not just functional, but also compact and lightweight.”
"Once you've got fusion-powered engines, you can get from here to Mars in weeks instead of months."
The founder of an AI-biologics discovery company recently told me that their algorithm designs a trillion new therapeutic proteins per week. And there are dozens of such companies. Drug design is now commoditized.
The current bottleneck for AI to actually improve human health is in the infrastructure needed to make and test the tsunami of new AI-designed drugs that are coming. To address this, the AI companies will need to go beyond understanding biology. They will need to control biology directly. I wrote an essay on why.
https://t.co/w24nyXhilW
Curious to hear your thoughts @elonmusk@DarioAmodei@sama@demishassabis
cool to see the bots getting easier for general adoption. actually usable, getting onto the factory floor, and set up by the people already working there.
What does AI really mean for robots? Start with this: anyone on your floor can use one.
At Standard Bots, we’re focused on building robots that are easy to use. Set up a routine in minutes from an iPad. Show your robot how it’s done, and it learns by demonstration. No robotics experience required.
When a robot is that easy to use, the people who know the work can put it to work. Machining, welding, palletizing, assembly, finishing, inspection, and more, run by the team you already have.
More parts out the door. More shifts covered. More capacity to compete.
That's what AI means for robots, and for manufacturing as a whole. Intelligent robots are the essential power tool of the 21st century.
Listen to our AI launchast: https://t.co/CKy0956leh
Today we're announcing our partnership with Zylidac, a state-of-the-art CDMO owned by the Pharma giant @ZydusUniverse Group. We're excited to be working with this veteran team that has brought over 30 molecules into the clinic. They understand that the digital control over biology that Prolific uniquely enables is going to be essential for manufacturing the coming wave of new medicines. Zylidac are not the only CDMO we are working with, but they will be the first to receive our GMP 2KL illuminators, due to their extreme proximity to our HQ (5min walk).
For anyone who was curious about trying Optogenetic Biomanufacturing, but was worried about the lack of a GMP scale path, one now exists at Zylidac. And more options will be coming online soon. We have a growing waitlist of deployments scheduled for 2027 and 2028.
Congrats to @stelliostech and @DrStarson.
American high-energy power, from counter-drone defense to compact fusion.
Proud to back you at pre-seed, and this is just the beginning.
first post. we just co-led @Deniz_H_Kent's $50M Series B2 in @ProlificMachine alongside Nant Capital. they're using light to control living cells, the manufacturing layer AI-designed biology has been missing.
incredible founders and lucky to back them. expect more on the rounds we're doing, plus a few ramblings along the way
@vkhosla@CellinoBio one piece of the puzzle and an incredibly important one. to actually get to printing organs you need cell based control systems, and right now there's really only one person doing that, @Deniz_H_Kent from @ProlificMachine